[
    [
        {
            "time": "2019-01-01",
            "original_text": "2019年疫苗监管趋严，康泰生物等3家主板上市疫苗企业股价应声下跌",
            "features": {
                "keywords": [
                    "疫苗",
                    "监管趋严",
                    "康泰生物",
                    "主板上市",
                    "股价下跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2019年疫苗监管趋严，康泰生物等3家主板上市疫苗企业股价应声下跌",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]